BioLineRx Ltd.: BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies ...
A Strong Foundation for 2025. Regions Financial Corp. reports 2024 earnings of $1.8 billion, earnings per diluted share of $1.93
Regions Financial Corp. (NYSE:RF) today reported earnings for the fourth quarter and full-year ended Dec. 31, 2024. The company reported fourth quarter net income ...